The archive.
Three decades of brand work across 7 engagements documented in this practice. Filter by category or browse the full archive.
A women's health brand, elevated.
Evofem held the science. They needed a brand that could hold the conversation. We rebuilt the visual system around education, agency, and trust, then shipped a digital experience that respected the patient's intelligence.
Inhaled therapeutics, made legible.
Brand identity, narrative video, and educational systems for a company building inhaled biologics. We translated mechanism into metaphor without losing the underlying truth.
A brand built to raise capital.
Aspargo came to us pre-funding. We built the identity that helped them tell the story to the people who write the checks.
One company. Two audiences.
A diagnostics company speaking to clinicians and to patients. We architected two identities under one strategy (Synaps DX and DISCERN™) so neither audience was diluted.
From unknown to listed.
Brand awareness from zero, plus the IR materials that carried Tyme through their NASDAQ transition.
A second listing. A second voice.
Angion's science had matured. Their brand had not. We expanded the visual and narrative system to match the company's clinical ambition, then carried it through the NASDAQ transition with IR-grade rigor.
"The weight is over." Three words. A category.
A GLP-1 era consumer health brand that needed to compete with the loudest category in pharma without joining the noise. We built a brand voice that was confident enough to be quiet, and a campaign system that earned attention by withholding it.
Begin a conversation.
Sixty minutes. No deck. We ask about your science, your audiences, and what your last agency got wrong.